Literature DB >> 1458032

Severity of dependence and route of administration of heroin, cocaine and amphetamines.

M Gossop1, P Griffiths, B Powis, J Strang.   

Abstract

This study investigates severity of dependence upon heroin, cocaine and amphetamines in a group of 200 heroin users, 75% of whom were not in contact with any treatment agency. For drug takers who were current users of more than one drug, heroin produced more severe dependence than either cocaine or amphetamine and many users of these stimulant drugs reported having experienced no problems of dependence. Severity of dependence was influenced by route of administration as well as type of drug. Heroin taken by injection was associated with more severe dependence than smoked heroin. For cocaine, injection and smoking were associated with equivalent dependence ratings, and both of these routes were associated with more severe dependence than cocaine used intranasally. For amphetamine, there were no differences in severity of dependence ratings for injection, intranasal or oral use. Severity of dependence was correlated with dose and duration of drug use; it was also associated with previous attendance at a drug treatment agency, though dependence problems were also common among heroin users who had never received treatment. Implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458032     DOI: 10.1111/j.1360-0443.1992.tb02660.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  95 in total

1.  Characteristics of heroin and cocaine users unknown to treatment agencies. Results from the Swiss Hidden Population Study.

Authors:  D Hausser; D Kübler; F Dubois-Arber
Journal:  Soz Praventivmed       Date:  1999

2.  The rate of intravenous cocaine administration determines susceptibility to sensitization.

Authors:  Anne-Noel Samaha; Yilin Li; Terry E Robinson
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

3.  Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users.

Authors:  Christian Haasen; Michael Prinzleve; Michael Gossop; Gabriele Fischer; Miguel Casas
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

4.  Cigarette smoking, illicit drug use, and routes of administration among heroin and cocaine users.

Authors:  P T Harrell; R C Trenz; M Scherer; L R Pacek; W W Latimer
Journal:  Addict Behav       Date:  2012-01-17       Impact factor: 3.913

5.  Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.

Authors:  Phoebe A Cushman; Jane M Liebschutz; Bradley J Anderson; Merredith R Moreau; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2016-06-11

6.  Effects of chronic and acute stimulants on brain functional connectivity hubs.

Authors:  Anna B Konova; Scott J Moeller; Dardo Tomasi; Rita Z Goldstein
Journal:  Brain Res       Date:  2015-02-24       Impact factor: 3.252

7.  Replication of ZNF804A gene variant associations with risk of heroin addiction.

Authors:  D B Hancock; J L Levy; N C Gaddis; C Glasheen; N L Saccone; G P Page; L J Bierut; A H Kral; E O Johnson
Journal:  Genes Brain Behav       Date:  2015-10-20       Impact factor: 3.449

8.  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.

Authors:  Eric A Woodcock; Leslie H Lundahl; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2015-04-24

Review 9.  Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.

Authors:  Stephen Brimijoin; Xiaoyun Shen; Frank Orson; Thomas Kosten
Journal:  Expert Rev Vaccines       Date:  2013-03       Impact factor: 5.217

10.  The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction.

Authors:  Anne-Noël Samaha; Nicolas Mallet; Susan M Ferguson; François Gonon; Terry E Robinson
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.